Completion of a significant clinical study

Completion of a significant clinical study - Axcellant

Completion of a significant clinical study

  1. lut 01, 2024

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study.

This study was meticulously designed to evaluate the performance and safety of a novel wound dressing technology in real-world settings. Emphasizing safety and performance, the study aimed to gather comprehensive data on the expected outcomes and to vigilantly monitor for any expected and unexpected adverse events. The study was completed ahead of schedule.

The success of this study is a testament to the collaborative effort of our dedicated team and the participating medical professionals, who navigated these challenges with expertise and commitment.

If you are interested in any type of medical devices study, please do not hesitate to contact us.

Patrycja Buczak-Kula

Read more

We are delighted to share exciting news from our team at Axcellant!

Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…

Unveiling Real-World Evidence in Clinical Trials

In the ever-evolving realm of pharmaceuticals and healthcare, a remarkable transformation is afoot - one that's reshaping the way we…